Personalized Medical Care & Dedicated International Patient Concierge

4.9 Patient Satisfaction

en-US

Medical Clinic LogoMedical ClinicHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesBefore & AfterReviewsAbout UsContact Us
Stem Cell Therapy and the Immune System: A Patient Guide

Medical Guide

Stem Cell Therapy and the Immune System: A Patient Guide

How stem cell therapy is studied to interact with the immune system and inflammation — a neutral, patient-friendly guide to the research and safety.

Schedule a Consultation

Medically reviewed by Dr. Seok Lee, Lead Physician, Pentaheal Medical Group

One of the most common questions patients ask about regenerative medicine is how stem cell therapy and the immune system relate to one another. It is a reasonable question, because inflammation and immune activity sit at the center of so many chronic conditions. This guide explains, in plain and neutral language, how regenerative and mesenchymal stem cell (MSC) therapy is studied to interact with immune and inflammatory processes — emphasizing that this is an area of active research rather than proven treatment. We will also cover an important safety point that Pentaheal Medical Group documents clearly: an acute autoimmune flare is a reason not to proceed. Throughout, our aim is to inform you, not to make promises.

Let us be clear at the outset. Regenerative medicine's relationship with the immune system is being explored by scientists, and much remains unknown. Stem cell therapies of this kind are not approved by the U.S. Food and Drug Administration (FDA) for effectiveness in immune or inflammatory conditions, and nothing here should be read as a claim that stem cell therapy treats, cures, or reverses any disease.

A quick refresher: the immune system and inflammation

To understand the research questions, it helps to understand the basics. The immune system is your body's defense network — a coordinated system of cells, tissues, and organs that protects you from harmful invaders such as bacteria and viruses. As the U.S. National Institute of Allergy and Infectious Diseases (NIAID) describes, the immune system distinguishes the body's own healthy tissue from foreign or harmful material and responds accordingly.

Inflammation is one of the immune system's core tools. In the short term, inflammation is a normal, protective response: it helps the body fight infection and heal injuries. Problems can arise when inflammation becomes chronic or when the immune system mistakenly targets the body's own tissues. When the immune system attacks healthy cells, the result can be an autoimmune condition. According to MedlinePlus (from the U.S. National Library of Medicine), autoimmune diseases occur when the immune system attacks and damages the body's own tissues, and there are many different types affecting different parts of the body.

This background matters because it explains why researchers are so interested in whether regenerative cells can influence immune and inflammatory signaling — and why caution is essential when the immune system is already misfiring.

What "immunomodulation" means and why researchers study it

You may see the word immunomodulation in discussions of stem cell science. It simply means influencing or adjusting the activity of the immune system. In laboratory and clinical research, mesenchymal stem cells have been studied for signals they may release and interactions they may have with immune cells — with scientists investigating whether these interactions could help calm excessive inflammation or support a more balanced immune response.

It is important to frame this accurately. This is an area of active research. Studying something is not the same as proving it works, and results seen in a laboratory or early study do not translate into a guaranteed benefit for any individual patient. Pentaheal's own language reflects this careful, exploratory framing: the clinic describes regenerative therapies as "studied for their potential" to support tissue repair and recovery, not as established cures. No efficacy, disease-treatment, or guaranteed-outcome claims should be drawn from this research, and individual results vary.

How Pentaheal frames regenerative care around inflammation

Pentaheal describes its regenerative work — including non-surgical mesenchymal stem cell (MSC) regenerative therapy — as being aimed, in general terms, at helping to support the body's natural repair processes. For its stem cell therapy for degenerative conditions, the clinic states that treatment is intended to help repair damaged tissues, reduce inflammation, and support mobility and recovery. These are general, non-quantified statements, and the clinic does not publish success rates or outcome guarantees.

Consistent with its diagnostics-first philosophy, Pentaheal evaluates inflammatory markers as part of its precision diagnostic testing before any plan is made. The clinic's three-step model — functional health evaluation, precision diagnostic testing, and personalized treatment planning — includes assessing inflammatory responses alongside metabolic, hormonal, nutritional, and environmental factors. In other words, inflammation is something the clinic measures and considers, not something it claims to eliminate. You can read more about how these services are organized on the Pentaheal Medical Group website.

The most important safety point: acute autoimmune flares

Here is a safety nuance that deserves prominence. Because the immune system is complex, and because regenerative therapy's interactions with it are still being studied, an active immune problem can be a reason not to proceed.

Pentaheal documents specifically that certain autoimmune conditions during an acute flare are a contraindication — meaning stem cell therapy is not suitable at that time. This is a deliberate, protective screening rule. The clinic also lists other situations in which regenerative or stem cell therapy may not be suitable:

  • Active cancer, or a history of cancer requiring further evaluation
  • Severe active infections
  • Pregnancy (and breastfeeding, for tissue-regeneration therapies)
  • Severe thrombocytopenia (a very low platelet count)
  • Other uncontrolled medical conditions

Final eligibility is always determined through a comprehensive medical evaluation and diagnostic assessment by the treating physician. If you live with an autoimmune or inflammatory condition, this screening step is exactly where those factors are reviewed carefully, and where a physician decides whether regenerative therapy is appropriate for you at all.

Regenerative therapy does not replace standard care

This point cannot be overstated. Regenerative or stem cell therapy is not a substitute for standard immunologic care or disease-modifying treatment. If you have an autoimmune or inflammatory disease, the medications and monitoring prescribed by your treating specialist remain the foundation of your care. Exploratory regenerative approaches should never be used as a reason to stop, delay, or replace established treatment.

Pentaheal presents regenerative medicine as part of a broader, individualized functional-medicine program under physician supervision — not as a stand-alone cure and not as a replacement for conventional care. Any decision about how regenerative care might fit alongside your existing treatment should be made together with both your regular physician and the clinic's physician.

What treatment involves, and possible side effects

For patients who are found suitable after evaluation, Pentaheal describes a structured process: consultation and assessment, advanced diagnostic testing, personalized planning, physician-supervised therapy, and structured follow-up. The clinic emphasizes quality-control measures such as sterile compounding with pharmaceutical-grade components, licensed biobank cell sourcing with sterility and viability testing, vital-sign monitoring during treatment, and continuous physician supervision so that protocols can be adjusted in real time.

The clinic is transparent that temporary side effects can occur. For its stem cell therapy for degenerative conditions, it reports that some patients experience temporary fatigue (in roughly 40–60% of cases), mild fever within the first 24 hours (roughly 15–20%), or a localized injection-site reaction where applicable (roughly 5–10%). A rare systemic inflammatory response is reported in fewer than 1% of cases. These figures are the clinic's own reported observations, and comprehensive screening before treatment is intended to help minimize risks. Recovery is described as gradual, with light daily activities often possible soon after and biological changes continuing over weeks to months.

One point worth noting: because the therapy interacts with the body's biology, a short-term inflammatory-type reaction (such as mild fever or fatigue) can be part of the early response for some patients. This is different from a therapeutic claim about "reducing inflammation" in a disease, and it is one more reason that physician supervision and follow-up matter.

An honest note on regulation and the FDA

Neutrality here is essential. Stem cell and regenerative therapies of this kind are not approved by the U.S. FDA for effectiveness for immune or inflammatory conditions. The FDA has issued consumer alerts warning that many marketed stem-cell and regenerative products are unapproved and that patients should be cautious, particularly regarding claims that such products can treat a wide range of diseases.

Pentaheal operates under South Korea's Advanced Regenerative Medicine framework and is registered with the Ministry of Health and Welfare as an institution for attracting foreign patients. These are Korean designations and are not equivalent to U.S. FDA approval. We encourage you to review the FDA's consumer information (linked below) and to weigh it carefully. The honest position is that immunomodulation research is promising enough to study but not settled enough to promise, and your decisions should reflect that reality.

Taking the next step

If you are considering regenerative care and have questions about how it might interact with an immune or inflammatory condition, the right next step is a personal medical evaluation. Candidacy and cost are confirmed at a reservation-based, paid consultation. You can reach the International Patient Team through the Pentaheal contact page to ask questions and begin the process.

The Bottom Line

  • Regenerative and MSC therapy is studied for how it may interact with immune and inflammatory processes (immunomodulation), but this is active research — not proven treatment.
  • Stem cell therapies of this kind are not FDA-approved for effectiveness for immune or inflammatory conditions, and the FDA has warned about unapproved products.
  • Pentaheal documents that an acute autoimmune flare is a contraindication, along with active cancer/history, severe active infection, pregnancy, and severe thrombocytopenia.
  • Regenerative therapy does not replace standard immunologic or disease-modifying care; keep working with your treating specialist.
  • Eligibility, benefits, and risks are individual; results vary, and there are no guarantees. A comprehensive evaluation decides suitability.

Frequently Asked Questions

**Does stem cell therapy "boost" or "fix" my immune system?**No. It is more accurate to say that researchers are studying whether mesenchymal stem cells interact with immune and inflammatory signaling — a concept called immunomodulation. This is an area of active research, not a proven treatment, and no one can promise it will boost or repair your immune system.

**Can regenerative medicine treat my autoimmune disease?**No such claim can be made. Stem cell therapies are not FDA-approved for effectiveness in immune or inflammatory conditions, and Pentaheal frames its regenerative care as exploratory. If you have an autoimmune disease, regenerative therapy is not a substitute for your prescribed, disease-modifying care.

**Why is an autoimmune flare a reason not to proceed?**Pentaheal documents that certain autoimmune conditions during an acute flare are a contraindication — meaning treatment is not suitable at that time. Because the immune system is highly active and unpredictable during a flare, this protective screening rule helps prioritize your safety.

**Who else may not be suitable for treatment?**The clinic lists active cancer or a cancer history requiring further evaluation, severe active infections, pregnancy (and breastfeeding for tissue-regeneration therapies), severe thrombocytopenia, and other uncontrolled medical conditions. Final eligibility is always determined through a comprehensive medical evaluation.

**Could the therapy itself cause inflammation?**The clinic reports that some patients experience temporary reactions such as mild fever within the first 24 hours (roughly 15–20% of cases) or temporary fatigue (roughly 40–60%), with a rare systemic inflammatory response in fewer than 1% of cases. These are short-term reactions, and screening plus physician supervision are used to help minimize risk.

**Will I still need my regular medications?**Yes, unless your own treating physician advises otherwise. Regenerative therapy does not replace standard immunologic or disease-modifying treatment. Any coordination between your existing care and regenerative options should be discussed with both your specialist and the clinic's physician.

**Does the clinic test my inflammation levels?**Yes. Pentaheal's precision diagnostic testing may include inflammatory-marker evaluation as part of its three-step, diagnostics-first model. This helps a physician understand your situation, though it is used for planning and screening rather than as a promise of any specific result.

**Is this therapy approved by the FDA?**No. Stem cell and regenerative therapies of this kind are not FDA-approved for effectiveness for immune or inflammatory conditions, and the FDA has warned consumers about unapproved stem-cell products. Pentaheal operates under South Korea's regulatory framework, which is not equivalent to FDA approval.

This article is for general informational purposes and does not constitute individualized medical advice. Consult a qualified physician about your specific condition.

More Articles

Continue reading our clinical guides.

View All
Korean Board-Certified Care: Safety in Functional Medicine Standards

Korean Board-Certified Care: Safety in Functional Medicine Standards

Chronic spine, joint, and cancer-related pain affects millions of families across South Korea.

Learn More

Learn More
Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Discover Seoul Korea's top functional medicine clinic for Americans. PENTAHEAL's complete guide to autoimmune, chronic disease and longevity programs in 2026.

Learn More

Learn More
Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Seeking metabolic syndrome treatment Seoul Korea? PENTAHEAL Medical Group offers a 1:1 metabolic reset program led by Dr. Seok Lee. Book your consult today.

Learn More

Learn More

Medical Clinic

Dedicated to evidence-based medical care, personalized treatment planning, and comprehensive support for local and international patients.

Treatments

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksBefore & AfterPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Medical Clinic. All rights reserved.

Individual clinical results may vary. Please consult a board-certified specialist.